Apimeds Pharmaceuticals US, Inc.
AMEX: APUS
$2.86
Live
as on
Apimeds Pharmaceuticals US, Inc. Stock Performance
as on October 24, 2026 at 6:28 am IST
Day's Low
Day's High
$2.81$3.17
1.75%
Downside
10.84%
Upside
52 Week's Low
52 Week's High
$1.51$59.7047.20%
Downside
1987.41%
Upside
Apimeds Pharmaceuticals US, Inc. share price movements today
- Previous Close
- $3.16
- Open
- $3.17
- Volume
- 191.6K
- Market Cap
- $4.9M
- Day's Low - High
- $2.81 - $3.17
- 52 Week Low - High
- $1.51 - $59.70
Apimeds Pharmaceuticals US, Inc. Historical Returns
- 1 Month Return
- + 37.99 %
- 3 Month Return
- -51.63 %
- 1 Year Return
- -81.78 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Apimeds Pharmaceuticals US, Inc. Stock Fundamentals & Key Indicators
Check Apimeds Pharmaceuticals US, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.9M
EPS (TTM)
-49.289
Dividend Yield
0.00%
PE Ratio (TTM)
-0.07
Industry PE ratio
-9.79
PEG Ratio
0.00
Return On Equity TTM
-58.98%
Apimeds Pharmaceuticals US, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Apimeds Pharmaceuticals US, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| NA | $4.9M | NA | -0.07 | 0.00% | 0.00% | |
| Buy | $41.2B | NA | 63.90 | 47.54% | 1.08% | |
| StrongBuy | $24.2B | 206.16% | 18.64 | 86.14% | 0.00% | |
| Buy | $21.4B | 32.57% | -51.25 | 34.83% | 2.60% | |
| Buy | $44.3B | NA | 20.54 | 65.57% | 1.98% |
Stock Returns calculator for Apimeds Pharmaceuticals US, Inc. Stock including INR - Dollar returns
The Apimeds Pharmaceuticals US, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Apimeds Pharmaceuticals US, Inc. investment value today
Current value as on today
₹17,839
Returns
Returns from Apimeds Pharmaceuticals US, Inc. Stock
Dollar Impact
₹1,346 (+1.35%)
Indian Investors' Interest in Apimeds Pharmaceuticals US, Inc. Stock
Investment in Apimeds Pharmaceuticals US, Inc. Shares on INDmoney has grown by 11116.66% in the last 30 days, indicating increased investment activity.
Time period: to
Change:11116.66% versus previous 30 day period
Search interest for Apimeds Pharmaceuticals US, Inc. Stock has increased by 2292% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:2292% versus previous 30 day period
Apimeds Pharmaceuticals US, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Apimeds Pharmaceuticals US, Inc. Annual Profit & Loss
All numbers in Millions USD
Apimeds Pharmaceuticals US, Inc. Quarterly Cash Flow
All numbers in Millions USD
Apimeds Pharmaceuticals US, Inc. Annual Cash Flow
All numbers in Millions USD
Insights on Apimeds Pharmaceuticals US, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Viatris Inc. Common Stock has given 79.2% return, outperforming this stock by 161.0%
NEGATIVE IMPACTPrice Dip
In the last 7 days, APUS stock has moved down by -21.8%
About Apimeds Pharmaceuticals US, Inc.
| Organisation | Apimeds Pharmaceuticals US, Inc. |
| Headquarters | 100 Matawan Rd, Matawan, NJ, 07747, US |
| Industry | Biotechnology |
| CEO | Vinod Menon |
Key Management of Apimeds Pharmaceuticals US, Inc.
Name | Title |
|---|---|
Mr. Amardeep Singh | Chief Technology Officer |
Mr. Erik C. Emerson | President |
Dr. Vinod Menon | Founder & Co-CEO |
Mr. Sungjoon Chae | Co-CEO & Director |
Mr. Eric Michael Sherb C.P.A. | Chief Financial Officer |
Captain Sandeep Singh Yadav | Chief Operating Officer |
FAQs
What is Apimeds Pharmaceuticals US, Inc. share price today?
Apimeds Pharmaceuticals US, Inc. share price today is $2.86 as on . Apimeds Pharmaceuticals US, Inc. share today touched a day high of $3.17 and a low of $2.81.
What is the 52 week high and 52 week low for Apimeds Pharmaceuticals US, Inc. share?
Apimeds Pharmaceuticals US, Inc. share touched a 52 week high of $59.70 on and a 52 week low of $1.51 on . Apimeds Pharmaceuticals US, Inc. stock price today i.e. is trending at $2.86,which is 95.21% down from its 52 week high and 89.40% up from its 52 week low.
What is Apimeds Pharmaceuticals US, Inc.'s market capitalisation today?
Apimeds Pharmaceuticals US, Inc. market capitalisation is $0.00T as on .
How to invest in Apimeds Pharmaceuticals US, Inc. Stock (APUS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Apimeds Pharmaceuticals US, Inc. on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Apimeds Pharmaceuticals US, Inc. Stock (APUS) from India?
Indian investors can start investing in Apimeds Pharmaceuticals US, Inc. (APUS) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Apimeds Pharmaceuticals US, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Apimeds Pharmaceuticals US, Inc. share’s latest price of $2.86 as on October 24, 2026 at 12:58 am IST, you will get 3.4965 shares of Apimeds Pharmaceuticals US, Inc.. Learn more about
fractional shares .